In the absence of arousal stimuli, the activity of the Rho-kinase-mediated signaling pathway promotes vasoconstriction of the cavernosal arterioles and sinuses, keeping the penis in the nonerect state. Upon sexual arousal or during nocturnal tumescence, nitric oxide (NO), released from nonadrenergic/noncholinergic nerves or from local endothelial cells, induces cavernosal vasodilation, resulting in an elevation in blood flow and intracavernosal pressure to initiate the erectile response. Although NO is thought to be the principal stimulator of penile erection, the signaling mechanism(s) of NO-mediated cavernosal vasodilation is unknown. In this article, we will consider the novel hypothesis that NO induces penile erection through the inhibition of endogenous Rho-kinase-mediated vasoconstriction. Additionally, we will look downstream of Rho-kinase, introducing a potential role for various substrates in the mechanism of Rho-kinase-mediated constriction in the cavernosal vasculature.
Introduction

Physiology of the erectile response
Penile erection is determined by increased blood pressure in the cavernosal arterioles and sinuses. The vasculature of the erectile mechanism differs from most blood vessels as it is composed of arterioles and hollow sinuses, both of which are lined with smooth muscle and endothelial cells. 1, 2 Contraction of smooth muscle narrows the arteriolar lumen and sinusoidal cavities, restricting blood flow to maintain low intracavernosal pressure and a flaccid penis. During sexual arousal or nocturnal penile tumescence, the release of nitric oxide (NO, predominantly through the activation of nonadrenergic/noncholinergic (NANC) nerves and local endothelial cells) initiates smooth muscle relaxation. [1] [2] [3] [4] [5] [6] The dilation of the cavernosal arterioles and sinuses results in increased blood flow (driven by the force of the arterial blood pressure) and a subsequent rise in intracavernosal pressure (ICP).
This initial rise in ICP activates a veno-occlusive mechanism to limit the outflow of blood and further increase the pressure inside the cavernosum, resulting in penile erection. 7, 8 Although vasodilators such as acetylcholine, [3] [4] [5] [6] prostaglandin F 2 , 2 and vasoactive intestinal peptide [9] [10] [11] have been implicated in the erectile response, NO is thought to be the principal stimulator of cavernosal vasorelaxation and penile erection. Interestingly, the mechanism by which NO mediates dilation of the cavernosal vasculature has not been established. In this paper, we consider the novel hypothesis that NO inhibits the endogenous activity of Rho-kinase, blocking the maintained vasoconstriction characteristic of the flaccid state to result in penile erection. However, first we must discuss the role of Rho-kinase activity in maintaining cavernosal tissue in the flaccid state.
The downside of it all: cavernosal vasoconstriction
In the absence of arousal stimuli, cavernosal vasoconstriction maintains the penis in the nonerect state. Various studies have suggested the endogenous constriction to be mediated primarily by the sympathetic nerve release of norepinephrine [12] [13] [14] (aadrenergic agonist) and secondarily through the local production of endothelin-l [15] [16] [17] (angiotensin-ll 18 may also be a relevant vasoconstrictor in the cavernous tissue). Recent findings from our laboratory have established that a portion of both aadrenergic and endothelin-l-induced contraction is mediated by activity of the Ser/Thr kinase, Rhokinase (most likely through stimulation of RhoA, the upstream activator of Rho-kinase). 19, 20 RhoA/Rhokinase activity has been found to sensitize smooth muscle contractile filaments to intracellular Ca 2+ , promoting and maintaining vasoconstriction. [21] [22] [23] [24] We have demonstrated the important role of Rhokinase activity in the maintenance of cavernosal vasoconstriction and the flaccid state of the penis. 25 As previously published, the inhibition of Rhokinase with Y-27632 resulted in a concentrationdependent increase in ICP in an in vivo rat model. 25 Various studies have found the contractile effects of RhoA/Rho-kinase to be largely attributed to the Rhokinase-mediated inhibition of myosin light-chain (MLC) phosphatase through phosphorylation of the myosin-binding subunit. 22, 23, 26 MLC phosphatase inhibition results in the maintenance of phosphorylated MLC, thus promoting the binding of actin and myosin for force generation. Although the inhibition of MLC phosphatase is thought to be the primary mechanism of Rho-kinase-mediated vasoconstriction, the possibility exists that other downstream substrates of Rho-kinase also play a role in maintaining the penis in the nonerect state, an idea that will be discussed in more detail later in this article.
Upstream regulation of Rho-kinase: is NO-induced penile erection via the inhibition of Rho-kinase activity?
From NO to erection
Penile erection is primarily initiated by NO released from NANC nerves and local endothelial cells. NO stimulates smooth muscle cell soluble guanylate cyclase, leading to an increase in cyclic GMP levels (cGMP) and the subsequent activation of cGMPdependent protein kinase (cGK). NO/cGK signaling has been proposed to decrease intracellular Ca 2+ via the inhibition of L-type Ca 2+ channels and the activation of sarcoplasmic reticulum Ca 2+ ATPases, as well as induce cellular hyperpolarization through the activation of membrane K + channels. [27] [28] [29] NO also has other actions, such as the activation of ribosyl transferases and nitration of proteins, which could potentially contribute to its vasodilatory effect. [30] [31] [32] Overall, the majority of mechanisms explaining NO-induced vasodilation involve the NO/cGK-mediated decrease in cytosolic Ca 2+ concentrations. Interestingly, however, studies by Morgan et al and others have demonstrated in various vascular tissue that intracellular Ca 2+ levels increase only transiently upon agonist stimulation, during the initial phase of contraction. 33, 34 During the maintenance phase of agonist-induced contraction, the concentration of cytosolic Ca 2+ decreases to near basal levels. 33, 34 Thus, it is unlikely that the physiologic mechanism of NO-induced vasodilation involves a lowering of (already low) cytosolic Ca 2+ levels.
Interestingly, recent evidence suggests that NO may also induce cellular relaxation through the inhibition of the Ca 2+ -sensitizing, RhoA/Rhokinase signaling pathway. Studies by Sauzeau et al and others demonstrated NO/cGK signaling to inhibit the primary upstream activator of Rhokinase, the small G-protein, RhoA. 35, 36 Recombinant RhoA was phosphorylated by cGK at Ser-188, resulting in the inhibition of RhoA-induced stress fiber formation. 35 Additionally, sodium nitroprusside (SNP) and constitutively active cGK were demonstrated to inhibit the phenylephrine (PE) or lysophosphatidic acid-induced translocation of RhoA from the cytosolic to membrane fraction in rat aorta and NIH3T3 cells, respectively, a process indicative of the NO/cGK-mediated inactivation of RhoA. 35, 36 In a recent study, we found NO/cGMPmediated inhibition of Rho-kinase activity to be a primary mechanism of vasodilation in isolated rat aorta. 37 In the light of these findings, we hypothesize that the NO-induced inhibition of endogenous Rho-kinase activity is the principal mechanism of cavernosal vasodilation for penile erection (Figure 1 ).
Evidence for NO-induced inhibition of Rho-kinase in the cavernosal vasculature
Preliminary data from our laboratory supports the hypothesis that NO inhibits Rho-kinase activity to result in penile erection. Using an in vivo rat model, ICP/mean arterial pressure (MAP) was measured upon voltage stimulation (1-5 V) of the major pelvic ganglion, and vasoactive agents were administered through a cannula in the left corpus cavernosum. Studies from this lab have demonstrated electrical stimulation of the major pelvic ganglion to result in a voltage-dependent increase in ICP/MAP, a process that is inhibited by NO synthase blockade (and is thus attributed to NO release from NANC nerves). As previously reported, injection of the Rho-kinase inhibitor (Y-27632) resulted in a concentrationdependent increase in ICP/MAP. 25 Interestingly, however, an additional interpretation of the data indicates the effect of Rho-kinase inhibition (with 50 nmol Y-27632) to be potentiated in the presence of NO (released through a 1 V stimulation of the major pelvic ganglion). 25 Additional experiments show a similar potentiation of the effect of RhoUps and downs of Rho-kinase and penile erection K Chitaley et al kinase inhibition on ICP/MAP upon prior injection of the NO donor drug, NOR-1, into the cavernous sinuses. Together with the findings in other vasculature, these data, demonstrating that NO potentiates the effect of Y-27632, provide initial support for our hypothesis that NO-induced penile erection is through the inhibition of endogenous Rho-kinase constrictor activity.
Downstream regulation of Rho-kinase:
are alternate Rho-kinase substrates also involved in cavernosal vasoconstriction?
The first half of this article has centered around the potential upstream regulation of Rho-kinase activity by the vasodilator, NO. We will now shift focus and discuss events downstream of Rho-kinase activity, which may also play a potential role in the regulation of the erectile response. As discussed earlier, the vasoconstrictor actions of Rho-kinase are predominantly mediated by the inhibition of MLC phosphatase, promoting the phosphorylated state of MLC. 23, 24, 38 Preliminary data from our lab support a role for MLC phosphatase inhibition in the cavernosal vasculature. Briefly, in a previously described in vivo rat model, intracavernosal injection of the phosphatase inhibitor, sodium orthovanadate, concentration-dependently blocked the ICP/MAP response to a 5 V stimulation of the major pelvic ganglion (unpublished observation). However, this inhibition of the voltage-mediated increase in ICP/ MAP was not complete, suggesting the presence of an alternate downstream mediator of Rho-kinaseinduced vasoconstriction.
Indeed, Rho-kinase (a Ser/Thr kinase) is known to phosphorylate numerous other substrates in addition to MLC phosphatase. These downstream targets include MLC (independent of MLC phosphatase inhibition), adducin, calponin, CPI-17, LIM-kinase, intermediate filaments, the ezrin/radixin/moesin family proteins and undoubtedly others (Figure 2) . 39, 40 The effects of Rho-kinase-induced phosphorylation of some of these substrates may be localized to stress fiber formation, membrane ruffling and cell motility. However, some evidence suggests that various substrates may indeed play a role in the regulation of cellular contraction, an idea that we will consider further.
As previously mentioned, the phosphorylation state of MLC largely determines the extent of vascular smooth muscle tone. Although Rho-kinase-mediated regulation of MLC phosphorylation is primarily thought to occur through the inhibition of MLC phosphatase activity (thus blocking the dephosphorylation of MLC), some evidence also suggests that Rho-kinase can phosphorylate MLC directly at Ser-19 (the same site phosphorylated by MLC kinase). 23, 24, 41, 42 Although the direct phosphorylation of MLC by Rho-kinase is a plausible mechanism for vasoconstriction, to date this event has not been verified in vivo. Figure 1 Potential mechanism of NO-induced penile erection, involving the inhibition of RhoA/Rho-kinase activity. Various studies in other vascular beds, as well as preliminary data from our laboratory support the hypothesis that NO induces vasodilation through the cGK-mediated inhibition of RhoA/Rho-kinase constrictor activity. We hypothesize that the inhibition of endogenous Rho-kinase activity in the cavernosal vasculature is the primary mechanism of NO-induced penile erection. Figure 2 Potential involvement of various downstream substrates as a mechanism of Rho-kinase-mediated vasoconstriction. Various substrates including MLC, MLC phosphatase, CPI-17, calponin and adducin may be involved in Rho-kinase-mediated vasoconstriction. In the cavernosal vasculature, Rho-kinaseinduced constriction may be through the regulation of MLC phosphorylation levels (involving MLC phosphatase, MLC and/or CPI-17) or through alternate signaling mechanisms (mediated by calponin and/or adducin).
Ups and downs of Rho-kinase and penile erection K Chitaley et al Another modulator of MLC phosphorylation and thus of cellular contraction, CPI-17, may also mediate Rho-kinase-induced vasoconstriction. 40 Activation of CPI-17 results in the inhibition of MLC phosphatase activity. 43, 44 The principal regulator of CPI-17 is protein kinase C, which through phosphorylation events promotes inhibitory activity toward MLC phosphatase. 40 Recent studies have demonstrated that Rho-kinase also phosphorylates CPI-17, 43, 44 resulting ultimately in increased phosphorylation of MLC to promote potentially the nonerect state of the penis. Although Rho-kinase plays a large role in the regulation of MLC phosphorylation, additional Rho-kinase-mediated signaling events may effect cellular contraction through alternate mechanisms.
Another substrate of Rho-kinase, calponin, is a smooth muscle-specific F-actin-associated protein that inhibits the interaction of actin with myosin, thus favoring the relaxed state of vascular smooth muscle. 40 Recent studies have demonstrated the phosphorylation of calponin to block the binding of actin to calponin, and thus restore myosin-actin ATPase activity. 40 Interestingly, calponin can be phosphorylated by Rho-kinase 45 resulting in the promotion of cellular contraction. Thus, calponin must be considered as an additional potential downstream mechanism for Rho-kinase-mediated cavernosal vasoconstriction.
Adducin, a cellular protein that is primarily involved in the regulation of the cytoskelton, 39 represents another substrate that may play a role in Rho-kinase-mediated contraction. 40, 46 Adducin stimulates activity of the Na + /K + ATPase, leading to hyperpolarization and thus cellular relaxation. 47 Evidence suggests that Rho-kinase can phosphorylate adducin, promoting its interaction with structural proteins. However, interestingly, the phosphorylation of adducin by protein kinase C is associated with the inhibition of its cytosketal associating activity. 40, 46 The effects of the phosphorylation of adducin on the promotion of Na + /K + ATPase activity, have not yet been determined. Although preliminary, it is tempting to speculate that Rho-kinase-mediated phosphorylation of adducin may inhibit Na + /K + ATPase activity, leading to cellular depolarization and contraction; however, no data support this hypothesis to date.
Conclusion
We have previously demonstrated the importance of Rho-kinase in maintaining the endogenous constriction of the cavernosal vasculature for the nonerect penis. In this article, we discuss upstream and downstream mechanisms that may play a role in the regulation of Rho-kinase activity, and thus in the erectile state of the penis. We first hypothesize that NO induces cavernosal vasodilation through the inhibition of endogenous Rho-kinase constrictor activity, and introduce physiologic evidence to provide support for this novel mechanism of penile erection. We then also look downstream of Rhokinase activity, hypothesizing substrates additional to MLC phosphatase that may also play a role in the maintenance of Rho-kinase-mediated cavernosal vasoconstriction. The identification of additional signaling mediators of cavernosal vasoconstriction introduces novel targets in the Rho-kinase pathway for potential therapeutic intervention in the treatment of erectile dysfunction.
In summary, the discovery of the important role of Rho-kinase in the maintenance of the nonerect penis has significantly expanded our knowledge of the regulation of the erectile response. Additional research on both the upstream and downstream regulation of this key enzyme may aid in the development of essential novel therapeutic agents for the treatment of erectile dysfunction. Further, gene therapy techniques to overexpress regulators and inhibitors of this signaling cascade may also provide new approaches to the management of erectile abnormalities.
